| Trial Identifier: | D2615C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02546661 |
| Start Date: | October 2016 |
| Primary Completion Date: | March 2020 |
| Study Completion Date: | June 2024 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| English Translation | |
| English Translation | |
| Spanish Translation | |
| French Translation | |
| French Translation | |
| Spanish Translation |
| Country | Location |
|---|---|
| CA, AB | Edmonton, AB, CA, T6G 1Z2 |
| CA, BC | Vancouver, BC, CA, V5Z 4E6 |
| CA, ON | Toronto, ON, CA, M5G 2M9 |
| CA, QC | Montreal, QC, CA, H3T 1E2 |
| ES | Badalona, ES, 08003 |
| ES | Barcelona, ES, 08035 |
| ES | Barcelona, ES, 08041 |
| ES | Madrid, ES, 28040 |
| FR | Bordeaux, FR, 33075 |
| FR | CAEN, FR, 14000 |
| FR | LYON cedex 08, FR, 69373 |
| FR | MARSEILLE CEDEX 9, FR, 13273 |
| FR | Saint Herblain Cedex, FR, 44805 |
| FR | Toulouse Cedex, FR, 31100 |
| GB | Glasgow, GB, G12 0YN |
| GB | London, GB, W1G 6AD |
| GB | London, GB, EC1M 6BQ |
| GB | Manchester, GB, M20 4BX |
| GB | Southampton, GB, SO16 6YD |
| US, CA | Los Angeles, CA, US, 90095 |
| US, CT | New Haven, CT, US, 06510 |
| US, FL | Ft Myers, FL, US, 33901 |
| US, NY | New York, NY, US, 10116 |
| US, NY | New York, NY, US, 10029 |
| US, NY | New York, NY, US, 10032 |
| US, OH | Cleveland, OH, US, 44195 |
| US, TN | Nashville, TN, US, 37203 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company